|
|
|
Journal of Bacteriology, November 2003, p . 6225-6232, Vol . 185, No . 21 Putative Interhelical Interactions within the PheP Protein Revealed by Second-Site Suppressor AnalysisC . Dogovski, J . Pi, and A . J . Pittard* Department of Microbiology and Immunology, The University of Melbourne, Victoria 3010, Australia Received 17 March 2003/ Accepted 30 July 2003
The proposed topological model of PheP shows that transmembrane spans I and II are closely associated with a tight periplasmic turn . Comparison of the amino acid sequences of members of the AAT family has shown that many residues found in span I and a smaller number of residues located in span II are very highly conserved in most members of the family . Spans I and II are also characterized by a relatively large number of highly conserved glycine residues . Glycine residues are commonly found in transmembrane spanning segments of membrane proteins (2, 11), and several studies have shown that these residues play a number of roles, including helix capping, modulation of helix flexibility, and mediation of close helix-helix association (22, 3, 10) . The presence of glycine residues at helix-helix interfacial positions allows close approach of interacting helices because of the small size of the glycine side chain . Additional studies designed to identify helix packing motifs have shown that the sequence GXXXG can mediate high-affinity homo-oligomerization (7, 23) . Evidence that glycine residues provide the basis for a close association between interacting helices also comes from studies which have shown that in general, glycine does not form packing voids in folded membrane proteins and has higher packing values than larger hydrophobic residues (3) . In this study, we investigated close helix packing by identifying the highly conserved small residues whose replacement by amino acids with larger side chains leads to a loss of transport activity and by showing that for some of these residues transport activity can be restored by complementary changes (large to small) in residues in other helices . In this way, we identified close helix packing between helices I and II and also between helices I and III . A possible role for some of the other highly conserved residues is also discussed below .
Recombinant DNA techniques. Standard recombinant DNA techniques were used essentially as described by Sambrook et al . (25) . Site-directed mutagenesis and sequence analysis. Oligonucleotide-directed site-specific mutagenesis was used to introduce various amino acid substitutions into the pheP gene by the method described by Vandeyar et al . (26) . mpMU3137 (17), a construct containing a modified pheP gene (with ATG instead of GTG as the start codon), was used as a template for mutagenesis . DNA sequencing of the entire pheP gene was performed to verify all the mutations . Automated DNA sequencing was performed with a model 377 DNA sequencer and ABI BigDye terminators (Perkin-Elmer Corporation) . Transport assays. Active transport was measured as previously described (27) . Briefly, wild-type and mutant pheP alleles carried on plasmid pLG339 were transformed into E . coli strain JP7910 . Cultures were grown in half-strength buffer 56 containing 0.2% glucose, the appropriate growth factors, and kanamycin at 37°C to an optical density at 600 nm of 0.45 . Cells were washed in half-strength buffer 56 containing 0.2% glucose and chloramphenicol (80 µg/ml) . Samples were preincubated at 30°C for 5 min before L-[14C]phenylalanine was added to a final concentration of 10 µM . Aliquots (150 µl) were removed at the appropriate times and filtered through cellulose acetate filters, which were then washed twice with half-strength buffer 56 . Intracellular activity was determined by liquid scintillation counting . Assays were done at least twice, and the variation in uptake values obtained in repeat tests was <10% . Pulse-labeling and immunoprecipitation. Cells harboring a plasmid expressing wild-type and mutant forms of PheP permease were cultured under the conditions described above for the transport assays and were grown to an optical density at 600 nm of 0.5 . Aliquots (0.5 ml) of the cell culture were pulse-labeled with 50 µCi of [35S]methionine-cysteine for 1 min at 37°C . Cell extracts were prepared and immunoprecipitated by using the method specific for integral membrane proteins described by Ito and Akiyama (8) . Specific proteins were precipitated with antiserum TTP7, which binds PheP permease . Samples were electrophoresed on sodium dodecyl sulfate-12% polyacrylamide gels . Each dried gel was exposed to X-ray film for at least 48 h . The densities of the radioactive bands were measured by scanning the autoradiographs with a Molecular Dynamics scanning densitometer, and the values were used to estimate the levels of mutant proteins relative to the levels of the wild-type proteins . Pulse-chase labeling. Cells expressing wild-type and mutant forms of the PheP protein were cultured by using the conditions described above for pulse-labeling and immunoprecipitation . Aliquots (2 ml) of the culture were labeled with 200 µCi of [35S]methionine-cysteine for 1 min at 37°C . Incorporation of radiolabeled amino acid was stopped after 1 min by addition of excess nonradioactive methionine-cysteine (200 µg/ml) . Samples (0.5 ml) were taken 1, 5, 15 and 30 min after quenching for immunoprecipitation . Random mutagenesis and screening for second-site suppressor mutations. Random mutations were introduced into a pheP allele carrying a primary site null mutation by propagating a plasmid containing this gene in the mutator strain XLI-Red for three overnight cycles . Plasmids were harvested and then transformed into strains JP4538 and JP7912, which lacked the ability to synthesize phenylalanine and tyrosine, respectively . Transformed strain JP4538 was plated onto minimal medium containing 10-5M phenylalanine, while transformed strain JP7912 was plated onto minimal medium containing 10-5 or 10-6 M tyrosine . These media could only support the growth of cells capable of transporting phenylalanine and tyrosine, respectively (i.e., wild-type revertants or suppressed mutants) . Plasmids from colonies showing the capacity to grow on these media were harvested and sequenced .
Replacement of other residues in spans I and II. The remaining 27 residues that comprise spans I and II consist of amino acids with side chains larger than those of alanine or glycine . These residues were replaced by smaller amino acids (either alanine, glycine, or valine) to determine whether reducing the side chain volume adversely affected the transport function . Only changes in three residues (T39, F42, and I49) significantly affected transport, even though a number of residues (I37, L41, F42, I49, P54, Y60, and M71) were highly conserved within the family (data not shown) . Replacement of T39 by alanine reduced the transport activity to 5% of the wild-type activity, replacement of F42 by valine reduced the transport activity to 14% of the wild-type activity, and replacement of I49 by alanine reduced the transport activity to 4% of the wild-type activity . Selection of second-site suppressors. Having identified a number of glycine residues in span I that are critical for activity, we decided to use second-site suppressor mutagenesis to identify any glycines in span I that might be involved in the close association between helices . In order to select second-site suppressors in primary mutants with mutations in the PheP protein, it was necessary to start with mutants that totally lacked transport activity . This is because the selection for suppressors was performed on minimal media supplemented with very low levels (10-5 to 10-6 M) of the amino acid being transported and experience has shown that even very low levels of transport activity in the original mutant are sufficient to allow growth to occur . The PheP transport protein transports both phenylalanine and tyrosine, but it has a 10-fold-higher affinity for phenylalanine (Km, 2 µM) than for tyrosine (Km, 30 µM) (1) . In a previous study in which second-site suppressors were selected (18), a transport-negative strain with a mutation (pheA) that prevented endogenous biosynthesis of phenylalanine was used . A number of the mutants in Table 1 exhibited low-level uptake of phenylalanine but fortunately were not able to transport tyrosine . Consequently, we introduced the mutant alleles into a transport-negative strain with a mutation (tyrA) that prevented tyrosine biosynthesis, and we were able to search for suppressed strains on minimal medium supplemented with very low levels of tyrosine . Eleven primary mutants (G34V, G34L, G35V, G38V, G38L, G40C, G40V, G40L, G40Y, G44V and G44L) which exhibited no transport activity for either tyrosine or phenylalanine were chosen for this study . Suppressed strains having primary substitutions at G34, G35, G38, or G44 were selected on minimal medium containing 10-5 or 10-6 M tyrosine by using the tyrA host, while suppressed strains having primary substitutions at G40 were selected on minimal medium containing 10-5 M phenylalanine with the corresponding pheA host . Plasmids carrying the pheP gene were isolated from 200 colonies which had grown on the selective medium, and these plasmids were then sequenced to confirm the presence of the primary mutation . Approximately 50% of the colonies that grew on selective medium were primary-site revertants and were not studied further . The pheP alleles that still retained the primary mutation were then fully sequenced in order to determine the type and position of any secondary mutations . Only five of the isolates were found to have a second-site mutation within pheP, and these isolates were used for further study, while the other isolates were discarded . The phenotypes of the five strains that were selected and the effects of the second-site mutations on transport activity are shown in Table 2 . Second-site suppressor mutations were not isolated in strains carrying the primary substitutions G34V, G34L, G38L, G40V, G40L, and G44L, and it is possible that replacement of glycine by leucine perturbed the structure too much to allow any compensating changes to restore function .
One suppressor mutation, a change at S323 to phenylalanine (S323F), significantly suppressed the defect in phenylalanine transport caused by the primary mutation G40Y, resulting in levels that were 30% of wild-type levels; at the same time the mutation did not have any effect on the inability of the mutant to transport tyrosine . According to the current topological model (17), the S323 residue is located within a cytoplasmic loop between spans VIII and IX, whereas G40 is located in the middle of span I . If the model is correct, it seems unlikely that there would be any direct interaction between these two residues, and the suppression effect of S323F in this case is most probably indirect . In a previous paper it was reported that the G40S change provides low-level suppression (4%) of the primary P341R null mutation (18), which is located at the C terminus of span IX . The second suppressor mutation affected the primary substitution G40C and involved a change in a span II residue, changing Y60 to cysteine . This suppressor mutation restored both the level of tyrosine transport and the level of phenylalanine transport to 15% of the wild-type levels (Table 2) . In contrast to the previous results, these two residues are located at about the same position in the membrane, since according to the topological model, G40 and Y60 are approximately in the middle of adjacent transmembrane spans, and this makes direct interaction a possibility . This possibility was investigated further, as described below . Effects of side chain volume at position 40 on efficiency of suppression. Starting with the primary mutant G40C, tyrosine 60 was changed to either alanine, serine, or methionine (Table 3) . Each of these changes restored activity; Y60A restored the activity to levels that were about 80% of the wild-type level, Y60M restored the activity to levels that were more than 130% of the wild-type level, and Y60S restored the activity to levels that were 101% of the wild-type level for phenylalanine and 50% of the wild-type level for tyrosine . In other words, the requirement for a glycine residue at position 40 is determined by the nature of the residue occupying position 60 in span II .
We constructed two more double mutants, G40V Y60A and G40L Y60A, but neither of these exhibited transport activity for either phenylalanine or tyrosine (data not shown) . Additional interactions between spans I and II. Figure 4a shows a helical wheel representation of residues in spans I and II, and Fig . 4b provides a possible lateral view of the helices within the membrane . In Fig . 4a the helical wheel plots demonstrate that residues I37, G44, L33, and G40 cluster on one side of span I, while residues L57, G64, M71, and Y60 are located on one face of span II . These residues are also shown in Fig . 4b lining one side of each transmembrane span . The residues indicated are located one helical turn apart along the length of each span . Since the data presented above provided evidence that there is a close interaction between residue G40 in span I and residue Y60 in span II, we investigated possible interactions between G44 and L57 and between I37 and G64 . The results are shown in Table 4 .
Similarly, the I37V change, when introduced into the primary mutant protein G64L, restored 20% of the phenylalanine transport activity and 12% of the tyrosine transport activity . In the wild-type protein, such a change alone caused a slight increase in transport activity . Second-site suppressors of a mutation changing the glycine at position 35. Strains containing the primary substitution G35V retained a low level of phenylalanine uptake (10% of the wild-type uptake), but the level of tyrosine transport was reduced to only 1% of the wild-type levels . Because of the relatively low affinity of the PheP protein for tyrosine, we endeavored to select suppressed strains on minimal medium containing 10-6M tyrosine . A mutant able to grow on this medium was isolated and subsequently shown to have a second mutation that caused a tyrosine-to-cysteine change at position 107 (Y107C) . In the current topological model position 107 lies within transmembrane span III close to the cytoplasm, whereas position 35 is closer to the center of span I . In this double mutant, phenylalanine and tyrosine uptake increased by 4.5- and 30-fold, respectively, to 45 and 30% the wild-type levels (Table 2) . In the wild-type protein the single Y107C change resulted in 2.6- and 2-fold increases in transport activity for phenylalanine and tyrosine, respectively (Table 5) .
Having established that a reduction in the side chain volume at position 107 could suppress the effects of a primary-site mutation which involved an increase in the side chain volume at position 35, we also wanted to test whether the Y107A change could suppress the effects of a number of other substitutions at position 35 (namely, G35A, G35V, and G35L) . Table 5 shows that the Y107A substitution significantly restored the transport activity for each of these primary changes . The suppression was most clearly seen with the suppressed G35L Y107A strain . In this case, the very low transport activities for phenylalanine and tyrosine (2 and 0%, respectively) observed in the single G35L mutant were increased to 43 and 42% of the wild-type levels in the G35L mutant with the Y107A suppressor . Specificity of Y107C and Y60C suppressor mutations. In the experiments described above, we showed that the Y107C change suppressed the effect of the primary-site G35V substitution . To further test the specificity of the Y107 suppressor, we tested the effect of the Y107C change on another primary-site mutant which produced a null phenotype, G40C . In this case there was no suppression of the original mutant phenotype (Table 6) . We also wanted to test the specificity of the Y60C suppressor, which suppressed the effect of the primary-site substitution G40C . Table 6 shows that the Y60C substitution did not suppress the effects of the G35V primary-site substitution . These results confirm the specificity of the suppression caused by changes at Y60 and Y107 .
Proposed interaction between spans I and II. The results clearly indicate that there is a close interaction between helices I and II, involving residues I37, G40, and G44 in span I and residues L57, Y60, and G64 in span II . Such a parallel association results in a tight hairpin-like structure, which might readily and spontaneously insert into the membrane in a manner suggested by Engelman and Steitz (4, 5, 21) . Changes to G40 which destroy transport activity, however, are not associated with a failure of the protein to insert into the membrane . On the other hand, the topology of the mutant proteins within the membrane has not been examined and may differ from that of the wild type . The presence of the glycine-tyrosine pair, involving spans I and II, is highly conserved among members of the AAT family (30 of 32 members) . Furthermore, in the case of PheP, replacement of the glycine at position 40 by either valine, leucine, cysteine, proline, or tyrosine completely destroys the transport function, and replacement by alanine reduces the level of phenylalanine transport to 12% of the wild-type level and eliminates transport of tyrosine . The strict requirements for the glycine at position 40 disappear when tyrosine 60 is changed . For example, when the tyrosine at position 60 is replaced by alanine, serine, or methionine, replacement of the glycine at position 40 by alanine or cysteine results in a protein with nearly wild-type levels of activity . Although it seems likely that the latter combinations can also provide a tight fit between helices I and II, the extraordinarily high levels of conservation of G40 and Y60 in the AAT family suggest that the interaction of these residues provides additional fitness to the protein, which is not measured in simple uptake experiments . Other examples of close packing between glycine and aromatic residues are found in the structure of cytochrome c (10) and bacteriorhodopsin (6) . The three glycine residues shown to be involved in the interaction between helices I and II (i.e., G40, G44 and G64) are all highly conserved and cannot be changed to other residues without dramatically affecting function . On the other hand, although I37 and Y60 are also highly conserved, replacement by smaller residues does not reduce the overall transport activity . One possibility that has not been tested is that the wild-type arrangement in all of the proteins may be important for the overall structure as it relates to the specificity of substrate selection and transport . Reducing the size of some of the residues, such as Y60, may increase the overall transport activity but decrease selectivity . The fact that G40V is not complemented by Y60A indicates that there are some special requirements for the amino acid at position 40 . Whether this is related to important constraints on helix packing or some other intrinsic feature of G40 has not been established yet . In light of these results, it is possible that the observed suppression of G40Y by S323F may involve major changes in the overall folding of the protein . Suppression of mutants with substitutions at G35. The finding that mutants such as the G35V and G35L mutants were suppressed by second-site changes affecting Y107 was unexpected because current topological models place Y107 much closer to the cytoplasmic border of the membrane than G35 . These models are, however, based on a standard transmembrane span of 20 amino acids, and as discussed recently, it is possible to consider a span III which extends from position 96 to position 126 (1) . Such an arrangement would place Y107 and G35 at about the same depth in the membrane . If the results that we obtained with the different substitutions reveal a close association between Y107 and G35, we would favor an interaction in which this represents a crossing point between the two helices rather than one region within a parallel association . The reason for this is that the extended face of span III involves F111, G115, E118, and A122 . It has previously been shown that changing F111 to either tyrosine or isoleucine extends the substrate range of the protein to include tryptophan (1) and that E118 is a highly conserved and important residue that may play a part in a proton relay system (16) . Consequently, we expect these residues to be exposed to some sort of aqueous channel rather than tightly packed against span I . Studies with AroP-PheP chimeras have shown that both G115 and A122 occur at side chain volume-sensitive positions (1) . However, in both these cases the proposed helices with which they interact are postulated to be more distal rather than preceding span III (1) . Conclusions. There are a number of conclusions that can be drawn from this work . The first is that second-site suppression combined with null mutants with conserved glycine residues has the potential to provide information on helix packing . The second is that the effects of increasing side chain volume in a residue in one helix can be partially compensated for by a decrease in the side chain volume of a specific residue in the interacting helix . The third is that the highly conserved spans I and II form a tight hairpin that appears to be essential for transport function . Fourth, span I also presents two other faces for interactions, with one face interacting with part of span III and the other face (GXXIG) interacting either with itself or with another span within the protein . Finally, we do not yet have a satisfactory explanation for the extremely high level of conservation of residues like Y60 and I37 in the AAT family and need to examine additional parameters in tests for phenotypic change .
This work was supported by the Australian Research Council Large Grants Scheme .
What Is Anthrax?,
What Is Dna?,
What Is Yeast?,
What Is Functional Genomics?,
What Is Botulism?,
o,
Microorganism,
e,
Microbes,
a,
Microorganisms,
s,
Microbiology,
r,
Bacterium,
o,
Culture medium,
a,
Antibiotic prophylaxis,
n,
Staphylococcus aureus,
r,
Escherichia coli,
c,
S. cerevisiae,
a,
Microbiological,
e,
Antimicrobials,
c,
Rhodococci,
s,
S. cerevisiae,
c,
Prokaryotes,
s,
S. cerevisiae,
c,
Lactococci,
n,
Botulism,
s,
Culture medium,
e,
Antibiotics,
s,
Xanthomonas,
e,
Antimicrobial,
i,
Escherichia coli,
o,
Ps. putida,
c,
S. cerevisiae,
c,
Morganella
|
© 2005
Transgalactic Ltd (manufacturer of Bioscreen C software) |
Privacy Statement | P.O. Box
1393, 00101 Helsinki, Finland,
Last modified: May 25, 2005
| ||||||